Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector ...

More than 600 lung transplants have been performed since Northwestern Medicine launched its lung transplant program back in ...

This program utilizes a technology known as ex-vivo lung perfusion, which has several components that allow the lung to remain in a physiologic state throughout transportation. The Organ Care System ...

We are pioneers of various innovations including the use of portable ex vivo lung perfusion for transportation and evaluation of donor organs. Our multidisciplinary team provides comprehensive care ...

More lungs were offered for transplantation from DCD donors than expected from historical organ yields, whether with ...

“In 2024, we used ‘lungs in a box,’ also known as lung perfusion, to repair the most number of donor lungs that were not initially usable,” said Chief of Thoracic Surgery Dr. Ankit Bharat.

An curved arrow pointing right. The XPS machine by XVIVO Perfusion, is changing the way doctors think about lung transplants. It's already cleared for use in Canada and Europe and is currently in ...

This makes the company’s heart and lung perfusion trials, international expansion and the introduction of a kidney device critical. Growth is likely to continue moderating until some of these ...

The machines, which cost six figures and are used during heart surgery, will now have to be repaired by the company directly.

Columnist Sam Kirton has spent years finding calm through a popular British phrase, which has allowed him to carry on through medical crises.

Getinge plans to phase out its surgical perfusion business in a move expected to benefit major players such as LivaNova, ...